ELPARA is a sterile intravenous formulation containing 500 mg of paracetamol in 50 mL solution (10 mg/mL). It is indicated for the management of mild to moderate pain and reduction of fever, especially in patients unable to take oral medications.

• Concentration: 10 mg/mL (500 mg/50 mL)

• Formulation: IV infusion (solution for injection)

• Classification: Analgesic/Antipyretic (Anilide)

DOBUKON is a single-dose intravenous inotropic agent containing 250 mg of Dobutamine Hydrochloride per 5 mL ampoule. It is primarily indicated for the short-term treatment of cardiac decompensation due to depressed contractility, as seen in heart failure or post-cardiac surgery patients.

• Concentration: 50 mg/mL (250 mg/5 mL ampoule)

• Formulation: Solution for Injection (IV Infusion)

• Classification: Adrenergic Agent (Sympathomimetic)

NICARDIZE is a sterile intravenous formulation, a potent vasodilator belonging to the dihydropyridine class of calcium channel blockers. It is used for the acute management of severe hypertension, including hypertensive emergencies, and is ideal for settings where rapid blood pressure control is critical.

• Concentration: 1 mg/mL (10 mg/10 mL)

• Formulation: Solution for Injection (I.V.)

• Classification: Calcium Channel Blocker

ELPITAZ is a broad-spectrum antibiotic combining Piperacillin and the β-lactamase inhibitor Tazobactam, effective against a wide range of resistant Gram-positive, Gram-negative, and anaerobic bacteria. It is indicated for hospital-acquired and ventilator-associated pneumonia, complicated intra-abdominal and urinary tract infections, skin and soft tissue infections, gynecologic infections, febrile neutropenia, and sepsis of unknown origin. Ideal for moderate to severe infections in hospital and ICU settings.

• Concentration: 4 g/500 mg

• Formulation: Powder for Injection (IV Infusion)

• Classification: Broad-Spectrum Antibiotic / β-Lactamase Inhibitor